Transcat, Inc. (NASDAQ:TRNS - Free Report) - Investment analysts at HC Wainwright issued their Q4 2026 earnings estimates for Transcat in a report issued on Wednesday, May 21st. HC Wainwright analyst S. Buck expects that the scientific and technical instruments company will earn $0.70 per share for the quarter. HC Wainwright currently has a "Buy" rating and a $116.00 price target on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share.
Several other equities research analysts have also recently commented on the company. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Tuesday, May 20th. Oppenheimer cut Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Finally, Northland Securities reiterated a "market perform" rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $114.00.
Get Our Latest Stock Analysis on TRNS
Transcat Stock Performance
Shares of TRNS stock traded up $1.21 during trading hours on Thursday, hitting $92.53. The stock had a trading volume of 39,064 shares, compared to its average volume of 81,989. Transcat has a twelve month low of $67.56 and a twelve month high of $147.12. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The stock's 50 day moving average is $79.84 and its 200 day moving average is $89.36. The firm has a market capitalization of $861.36 million, a PE ratio of 50.02 and a beta of 0.69.
Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). The firm had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. Transcat had a return on equity of 7.23% and a net margin of 6.22%. The business's revenue for the quarter was up 8.8% compared to the same quarter last year.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the company. Centiva Capital LP increased its position in shares of Transcat by 6.0% in the fourth quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company's stock valued at $318,000 after buying an additional 171 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Transcat by 0.6% in the first quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company's stock valued at $2,078,000 after buying an additional 172 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Transcat by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company's stock valued at $543,000 after buying an additional 194 shares in the last quarter. Diamond Hill Capital Management Inc. increased its position in shares of Transcat by 3.4% in the first quarter. Diamond Hill Capital Management Inc. now owns 6,353 shares of the scientific and technical instruments company's stock valued at $473,000 after buying an additional 210 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Transcat by 14.6% in the first quarter. US Bancorp DE now owns 1,770 shares of the scientific and technical instruments company's stock valued at $132,000 after buying an additional 226 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company's stock.
Transcat Company Profile
(
Get Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
